Actively Recruiting
Long-term Prognosis of Patients With Hepatitis B Related Acute-on-chronic Liver Failure
Led by Third Affiliated Hospital, Sun Yat-Sen University · Updated on 2024-11-29
300
Participants Needed
1
Research Sites
241 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study is to investigate the long-term outcomes and prognostic risk factors in patients recovered from hepatitis B virus related acute on-chronic liver failure.
CONDITIONS
Official Title
Long-term Prognosis of Patients With Hepatitis B Related Acute-on-chronic Liver Failure
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age from 18 to 65 years old
- Diagnosed with hepatitis B associated chronic acute liver failure
- Survived more than 90 days after hospitalization
- Complete inpatient clinical data available
You will not qualify if you...
- Infection with human immunodeficiency virus or congenital immune deficiency diseases
- Liver cancer, other tumors, autoimmune liver disease, genetic or metabolic liver disease, or other serious diseases affecting survival
- Any other condition deemed inappropriate for inclusion by the researchers
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Third Affiliated Hospital of Sun Yat-sen University
Guangzhou, Guangdong, China, 510630
Actively Recruiting
Research Team
L
Lu Wang, Doctor
CONTACT
L
Liang Peng, Doctor
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here